Abstract
Background
Bariatric surgeries are now redefined as metabolic surgeries given the excellent resolution of metabolic derangements accompanying obesity. Duodenojejunal bypass (DJB) is a novel metabolic surgery based on foregut hypothesis. Reports describe DJB as a stand-alone procedure for the treatment of diabetes in nonobese subjects. For obese subjects, DJB is combined with sleeve gastrectomy. This combination of DJB and sleeve gastrectomy is proposed as an ideal alternative to Roux-en-Y gastric bypass (RYGB) with these advantages: (1) easy postoperative endoscopic surveillance, (2) preservation of the pyloric mechanism, which prevents dumping syndrome, and (3) reduced alimentary limb tension. This study aimed to analyze the short-term outcomes of laparoscopic DJB with sleeve gastrectomy for morbidly obese patients.
Methods
At our institution, 38 patients who underwent laparoscopic DJB with sleeve gastrectomy were followed up. The inclusion criteria for the study were according to the Asian Pacific Bariatric Surgery Society guidelines. Sleeve gastrectomy was performed over a 36-Fr bougie, with the first part of the duodenum mobilized and transected. The jejunum was divided 50 cm distal to duodenojejunal flexure. A 75- to 150-cm alimentary limb was fashioned and brought in a retrocolic manner. End-to-end hand-sewn duodenojejunostomy was performed. Intestinal continuity was restored with a stapled jejunojejunostomy, and mesenteric rents were closed.
Results
The study population consisted of 38 patients (15 men and 23 women) ranging in age from 31 to 48 years. During a mean follow-up period of 17 months, the excess body weight loss was 72%, with a 92% resolution of diabetes. One patient presented with internal herniation through the retrocolic window 1 month after the operation and was managed surgically without any complication. No other minor or major complications occurred, and there was no mortality.
Conclusion
Laparoscopic DJB with sleeve gastrectomy is safe and effective in achieving durable weight loss and excellent resolution of comorbidities. Long-term follow-up studies are needed.
Similar content being viewed by others
References
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
Beckman LM, Beckman TR, Earthman CP (2010) Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 110:571–684
Rubino F et al (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61:393–411
Pories WJ, Albrecht RJ (2001) Etiology of type II diabetes mellitus: role of the foregut. World J Surg 25:527–631
Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up. Obes Surg 10(3):233–239
Higa KD, Boone KB, Ho T (2000) Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients: what have we learned? Obes Surg 10:509–513
Higa KD, Ho T, Boone KB (2001) Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A 11:377–382
Schauer PR, Ikramuddin S, Gourash W et al (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529
National Cancer Registry Programme (India). Consolidated report of hospital-based cancer registries 2001–2003. Indian Council of Medical Research. http://www.icmr.nic.in/ncrp/cancer_reg.htm
Sambasivaiah K (2004) Clinical profile of carcinoma stomach at a tertiary care hospital in South India. Trop Gastroenterol 25:21–26
Swaminathan R (2009) Cancer pattern and survival in a rural district in South India. Cancer Epidemiol 33:325–331
Ramos AC et al (2009) Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg 19:307–312
Cohen RV et al (2007) Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 3:195–197
Rubino F (2008) Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31(Suppl 2):S290–S296
Kasama K et al (2009) Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg 19:1341–1345
Lee WJ, Wang W (2005) Bariatric surgery: Asia-Pacific perspective. Obes Surg 15:751–757
Stefanidis D, Kuwada TS, Gersin KS (2011) The importance of the length of the limbs for gastric bypass patients: an evidence-based review. Obes Surg 21:119–124
Praveen RP, Chandramaliteeswaran C, Senthilnathan P, Asokan S, Palanivelu C (2010) Bariatric to metabolic surgery: management options and experience at a tertiary centre. J Indian Med Assoc 108:645–647
American Diabetes Association (2008) Standards of medical care in diabetes—2008. Diabetes Care 31(Suppl 1):S12–S54
Buchwald H (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
Buchwald H et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256
Gagner M (2010) Laparoscopic sleeve gastrectomy with duodenojejunal bypass for severe obesity and/or type 2 diabetes may not require duodenojejunal bypass initially. Obes Surg 20(9):1323–1324
Csendes A et al (2005) Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg 9:121–131
Khitin L, Roses RE, Birkett DH (2003) Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg 60:521–523
Escalona A et al (2005) Gastric cancer after Roux-en-Y gastric bypass. Obes Surg 15:423–427
Loss AB et al (2009) Analysis of the dumping syndrome on morbid obese patients submitted to Roux-en-Y gastric bypass. Rev Col Bras Cir 36:413–419
Padoin AV et al (2009) Obese patients with type 2 diabetes submitted to banded gastric bypass: greater incidence of dumping syndrome. Obes Surg 19:1481–1484
Navarrete SA, Leyba JL, Llopis SN (2011) Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in nonobese patients: technique and preliminary results. Obes Surg 21(5):663–667
Disclosures
Raj P. Praveen, R. Kumaravel, C. Chandramaliteeswaran, V. Vaithiswaran, and C. Palanivelu have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Praveen Raj, P., Kumaravel, R., Chandramaliteeswaran, C. et al. Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India. Surg Endosc 26, 688–692 (2012). https://doi.org/10.1007/s00464-011-1938-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-011-1938-0